Webinars and videos

This webinar provides information and guidance on the implementation of anti-inflammatory reliever (AIR) and Maintenance and Reliever Therapy (MART) treatment options children and young people, as well as adults.

This is the second webinar in the PCRS Maintenance and Reliever Therapy (MART) in asthma campaign. It provides information on anti-inflammatory reliever (AIR) and MART treatment options in the context of the new BTS/NICE/SIGN asthma guideline 2024 and associated implementation guidance.  

AstraZeneca has provided sponsorship towards this independent Programme and has had no involvement in its creation or organisation

At the Primary Care Respiratory Society (PCRS), we believe in 'optimal'; respiratory health for all. Our aim is that, together, we can benefit every person with, or at risk of, lung disease.

At the Primary Care Respiratory Society (PCRS), we believe in 'optimal'; respiratory health for all. Our aim is that, together, we can benefit every person with, or at risk of, lung disease.

Are you struggling to persuade your Integrated Care Board (ICB) to fund FeNO testing? With the new BTS/NICE/SIGN asthma guideline recommending FeNO for asthma diagnostic testing, this can create quite a challenging for primary care providers. There can also be uncertainty around when to use it and when not to and many will not be alone in this uncertainty.  

At the Primary Care Respiratory Society (PCRS), we believe in 'optimal'; respiratory health for all. Our aim is that, together, we can benefit every person with, or at risk of, lung disease.

Let's be MART for asthma.